Does CARFILZOMIB Cause Thrombophlebitis? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Thrombophlebitis have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.1% of all adverse event reports for CARFILZOMIB.
24
Reports of Thrombophlebitis with CARFILZOMIB
0.1%
of all CARFILZOMIB reports
0
Deaths
8
Hospitalizations
How Dangerous Is Thrombophlebitis From CARFILZOMIB?
Of the 24 reports, 8 (33.3%) required hospitalization, and 1 (4.2%) were considered life-threatening.
Is Thrombophlebitis Listed in the Official Label?
Yes, Thrombophlebitis is listed as a known adverse reaction in the official FDA drug label for CARFILZOMIB.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Thrombophlebitis?
ADALIMUMAB (94)
DEXAMETHASONE (85)
LENALIDOMIDE (84)
RITUXIMAB (76)
CYCLOPHOSPHAMIDE (73)
METHOTREXATE (62)
RIVAROXABAN (61)
ETHINYL ESTRADIOL\ETONOGESTREL (53)
DOXORUBICIN (51)
APIXABAN (48)
Which CARFILZOMIB Alternatives Have Lower Thrombophlebitis Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL